Simon Nitschky Schmidt

Vortioxetine for Major Depressive Disorder in Adolescents: 12-Week Randomized, Placebo-Controlled, Fluoxetine-Referenced, Fixed-Dose Study

Robert L. Findling, Melissa P. DelBello, Alessandro Zuddas et al. · Journal of the American Academy of Child & Adolescent Psychiatry · 2022 · 37 citations · Full text

Medicine, Pharmacology, Psychiatry +16

Effectiveness of vortioxetine in patients with major depressive disorder and early-stage dementia: The MEMORY study

Michael Cronquist Christensen, Simon Nitschky Schmidt, Iría Grande · Journal of Affective Disorders · 2023 · 35 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Effectiveness of vortioxetine in patients with major depressive disorder comorbid with generalized anxiety disorder: Results of the RECONNECT study

Michael Cronquist Christensen, Simon Nitschky Schmidt, Iría Grande · Journal of Psychopharmacology · 2022 · 31 citations · Full text

Medicine, Pharmacology, Psychiatry +17

Efficacy and safety of vortioxetine in treatment of patients with major depressive disorder and common co-morbid physical illness

David S. Baldwin, Oscar Necking, Simon Nitschky Schmidt et al. · Journal of Affective Disorders · 2022 · 25 citations · Full text

Medicine, Pharmacology, Psychiatry +17

Multidimensional Assessment of Functional Outcomes in Schizophrenia: Results From QUALIFY, a Head-to-Head Trial of Aripiprazole Once-Monthly and Paliperidone Palmitate

Steven G. Potkin, Jean‐Yves Loze, Carlos Forray et al. · The International Journal of Neuropsychopharmacology · 2016 · 24 citations · Full text

Pharmacy, Pharmacotherapy, Psychiatry +17